Phase II Study of HMPL-004 in Patients With Ulcerative Colitis
A Phase II, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis With or Without Mesalamine A Phase II, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients ...
Ulcerative Colitis
Drug: HMPL-004 low dose;Drug: Placebo;Drug: HMPL-004 high dose